October 2019

Endotronix Announces Partnership with Tyndall National Institute.

Endotronix, Latest News / By Victoire La Touche-Price

Dublin, Ireland. October 15, 2019. Seroba’s portfolio company, Endotronix Ireland Limited, a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced today an Enterprise Ireland Industry Partnership project in a collaboration with Tyndall National Institute, a leading European Deep Tech research center in integrated ICT (Information and Communications …

Endotronix Announces Partnership with Tyndall National Institute. Read More »

PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study.

Latest News, PQ Bypass / By Victoire La Touche-Price

Milpitas, California & Dublin, Ireland. October 8, 2019. PQ Bypass Announces Unconditional IDE Approval from U.S. FDA to Start TORUS SFA Stent Graft Pivotal Study (TORUS-2) Seroba’s portfolio company, PQ Bypass, Inc., a clinical-stage medical device company, today announced it has received full approval of its investigational device exemption (IDE) trial of the company’s TORUS …

PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study. Read More »

Endotronix Closes Expanded Series D Round.

Endotronix, Latest News / By Victoire La Touche-Price

Lisle, Illinois & Dublin, Ireland. Oct 1, 2019. Seroba’s investee company, Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure (HF), today announced the expansion of its Series D financing round, bringing the total for the round to $70 million. The expansion syndicate for the LSP-led round includes new …

Endotronix Closes Expanded Series D Round. Read More »

Endotronix Announces Partnership with Tyndall National Institute.

PQ Bypass Announces Unconditional IDE Approval from U.S. FDA for Pivotal Study.

Endotronix Closes Expanded Series D Round.

Seroba Life Sciences 18 Herbert Street, Dublin 2

T: 353 (0)1 633 4028